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COMMENTS
REPROCESSING AND REUSING SINGLE-USE
ONLY MEDICAL DEVICES: SAFE MEDICAL
PRACTICE OR RISKY BUSINESS?
Diane Carey*
INTRODUCTION
In early 1999, a piece of metal broke off of a catheter and lodged inside
the heart of a thirty-two year old Kansas woman.' The catheter was
designed and labeled by the manufacturer to be used only one time; yet in
2fact, it had been used six times. This incident reignited the debate over
the reuse of single-use only medical devices.3 Unfortunately, this was not
an isolated incident. Other incidents include the death of a patient in a
Colorado hospital due to a bacterial outbreak following the use of a
contaminated reused cardiac catheter,4 and reports of transmission of the
* J.D. Candidate May 2001, Columbus School of Law, The Catholic
University of America, Bachelor of Science in Nursing, 1996, George Mason
University. The author wishes to thank her parents for their support and
encouragement, Chris Corbey for his support, comments and suggestions and
Karen Petersen, fellow law student, for her support and assistance. The author
also wishes to thank the editors and staff of The Journal of Contemporary Health
Law and Policy for all their help.
1. Lauran Neergaard, Recycling of Medical Devices Prompts Debate Over
Budget, Risk, SAN DIEGO UNION & TRIBUNE, Aug. 14, 1999, at A9. Proponents of
reprocessing argue that new catheters can and have broken during use.
2. Debate, USA TODAY, Nov. 29, 1999, at 28A. The authors explain that the
practice does not involve low risk medical devices only, such as blood pressure
cuffs. Hospitals also reuse invasive devices such as biopsy needles, breathing
circuits, and cardiac catheters.
3. Neergaard, supra note 1.
4. 104 CONG. REC. S10107. (daily ed. Aug. 4, 1999) (statement of Sen.
Durbin). See Alexander Alger, Does Safety Sell?, FORBES MAG., Mar. 22, 1999, at
124. (There have also been reports of transmission of tuberculois, hepatitis B and
C, salmonella, and E. coli infections); Neil Weinberg, Blood Money, FORBES
MAG., Mar 22, 1999 at 123.
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hepatitis B virus when a single-use finger stick was used for blood
sampling on more than one patient.5 It has been reported that many
reused devices retrieved from hospitals in exchange for new devices either
had blood or tissue remaining on them, or were so damaged that they
could not have met the standards the Food and Drug Administration
6(FDA) had set for the original manufacturer.
Many hospitals in the United States and other countries reprocess and
reuse medical devices designed and labeled for single-use only. The
Health Industry Manufacturers Association (HIMA) defines reuse "[als
using a device for its intended use more times than is described in the
device's labeling."7 Currently, there are more than two hundred different
types of single-use medical devices.8 Single-use devices commonly
recycled include electrophysiology catheters used for cardiac testing;
biopsy forceps used for removing tissue samples; drills, bits, and blades
used in orthopedic surgery; and endoscopic retrograde
cholgiopancreatography (ERCP) catheters used to remove gallstones.9
These single-use devices are designed for hundreds of different purposes,
including diagnostics and treatments. ° Many of these devices are intricate
and complex and some are made of fragile components such as electrical
wires and hinges." Such devices are safe and effective when used initially,
but may not be durable enough to be cleaned, resterilized and used
5. John Lockhart, The Coalition for the Advocacy of Reuse Awareness'
Position on Reprocessing Single-Use Medical Devices, # 5 SURGICAL SERVICES
MGMT., Jan. 1999, at 42.
6. See CONG. REC., supra note 4.
7. Health Industry Manufacturers Association: Position Paper on the Reuse
of Single-Use Medical Device at 1. [Hereinafter HIMA].
8. Lockhart, supra note 5, at 42.
9. Weinberg, supra note 4, at 124; see Sylvia Pagan Westphal, Risky Reuse of
Medical Equipment is on the Rise, L.A. TIMES, Aug. 2, 1999, at Al. Other devices
include anesthesia breathing circuits, electro-surgical devices, respiratory therapy
breathing circuits, biopsy needles, and hemodialyzers. Dateline: Braced for the
Truth, (NBC Television Broadcast, Mar. 9, 1999) (transcript on file with author)
(stating that orthodontists routinely remove parts of braces that have been used in
one person's mouth, sterilize them and then use them in another person's mouth,
even though the manufacturer has labeled them for single-use only) ;
PROCEDURES 519 (HELEN KLUSEK HAMILTON et al., eds. 1985). An ERCP
procedure (endoscopic retrograde cholgiopancreatography), is a radiographic
examination of the pancreatic ducts and heptobiliary tree to evaluate the cause of
obstructive jaundice.
10. Lockhart, supra note 5, at 42.
11. Id.
Single- Use Medical Devices
again. 2 Single-use devices that are reused should not be confused with
medical devices that are designed to be reused and are made from
materials, such as stainless steel, which permit safe resterilization and
13reuse.
Until recently, there has been little public outcry about the practice of
reusing single-use medical devices because most patients and their
14
families are not aware of this practice. U.S. News and World Report calls
the practice "[m]edicine's dirty little secret."" Hospitals are under
pressure from health care insurers and Medicare to decrease costs.
Because of this pressure, thousands of hospitals in the United States
recycle millions of disposable instruments used for invasive procedures,
16such as cardiac angioplasty and orthopedic surgery.
Prior to 1980, almost all medical devices and instruments were made of
glass, rubber or metal.17 These devices were easy to clean and sterilize,
and therefore, safe to use for many different patients and procedures.18
However, with recent advances in plastic technology, medical devices
have become smaller, more flexible, and more intricate, allowing
physicians to treat patients less invasively.'9 For example, cardiologists
are using these devices to repair blocked blood vessels in the heart
12. Id.
13. Id.
14. Id.; See CONG. REC., supra note 4. Senator Durbin said, "When you go in
for heart surgery or these diagnostic treatments, it never crossed your mind to ask
the doctor: Incidentally, will all the devices you are going to use in the course of
my treatment be used for the first time?" Id. See Weinberg, supra note 4, at 126.
A nurse in Ohio notes, "If a cardiologist or some other important person
undergoes a procedure, the hospital uses a new instrument." The fact that
physicians do not want reused devices utilized on them sends an important
message. Id.
15. Dana Hawkins, News You Can Use: Risky Recycling, U.S. NEWS &
WORLD REPORT, Sept. 20, 1999, at 62. The majority of health care professionals
asked by U.S. NEWS AND WORLD REPORT if they would want reused devices used
on them or a family member said no. It is possible for a patient to protect himself
by inserting an additional line on the informed consent form stating "Do not
reuse single-use devices without my written permission." Although this is rarely
done, it does work. One physician says he only knows of it being done one time,
but the hospital complied and used a new catheter on the patient as requested. Id.
at 67.
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without resorting to open-heart surgery.'0
Against the advice of medical device makers, hospitals and outside
reprocessors take the devices, apply toxic chemicals and use high
temperatures to clean and sterilize the devices, then use the devices in
other patients.2 Hospitals and reprocessors have been able to do this
without federal or industry oversight.2  The practice of reprocessing
single-use medical devices is growing, with approximately forty million
23dollars spent annually on reprocessing.
The debate over reprocessed single-use medical devices continues.
Device manufacturers want to have the practice banned; reprocessors are
encouraging the growth of the practice; the FDA and Congress are trying
to decide how to regulate the practice; and the public is caught in the
middle, unaware and unprepared.
This Comment examines the debate over the reuse of medical devices.
Part I discusses recent congressional action. Part II addresses both the
benefits and risks of the practice and explains the proponents' and
opponents' views. Part III examines informed consent issues. Part IV
examines the ethics of experimentation and the studies that have been
conducted to determine whether or not it is safe to reuse single-use only
medical devices. Part V looks at product liability and warranty issues
implicated when single-use medical devices are reprocessed and reused.
Part V also examines patent issues and trademark infringement. Part VI
discusses the current position being advanced by the FDA. The author
concludes that the practice of reprocessing single-use medical devices
unnecessarily puts the American public at risk of illness or injury, and
should be banned until the safety and efficacy of the practice has been
determined satisfactorily.
I. CONGRESSIONAL ACTION
Senators Richard Durbin (D-IL) and Edward (Ted) Kennedy (D-MA)
addressed the United States Senate on August 3, 1999, regarding the
24reuse of single-use medical devices. Senator Durbin said the issue
20. Id.
21. See Weinberg, supra note 4, at 123.
22. Id.
23. Id. at 124.
24. 104 CONG. REC. S10170-10171 (daily ed. Aug. 4, 1999) (statements of
Sens. Durbin and Kennedy). Senator Durbin stated "One of the things we find is
that many of the instruments that are being used have been labeled single use and
are being so-called cleaned and reprocessed and used again." Id.
Single- Use Medical Devices
revolves around "[h]ighly invasive and high-risk devices, devices that
come in contact with the patient's blood or other bodily fluids." 25 Senator
Durbin expressed concern that reuse occurs without the knowledge of
patients and without a requirement that the devices be safe and effectiveS 21
after reprocessing. Senator Durbin told members of the Senate about
some of the known incidents that have occurred with reused devices. 27 He
then introduced legislation requesting one million dollars to aid the FDA
in monitoring the situation better and the Senate approved the request.
Senator Kennedy, in his remarks before the Senate, addressed the fact
that many of the single-use devices are made from heat sensitive plastics
and have intricate, inaccessible parts which can be difficult, if not
impossible, to clean and sterilize. 29 Referring to studies conducted by the
FDA on balloon angioplasty catheters, Senator Kennedy said, "[t]he
studies concluded that many of the narrow spaces in these catheters were
contaminated with blood, and that the balloons no longer inflated
properly."30
In a letter to the United States General Accounting Office (GAO), the
Committee on Health, Education, Labor and Pensions, chaired by
Senator James M. Jeffords (R-VT), noted that "The American public
relies on the FDA to ensure that medical devices are safe and effective. 31
The Committee asked the GAO to initiate a comprehensive evaluation of
the practice of reusing single-use medical devices."
25. CONG. REC. S 10170 (statement of Sen. Durbin), supra note 24.
26. Id.
27. Id. Senator Durbin said in his comments, "One has to wonder why we
spend any money on device safety if the device only has to be safe when it is used
initially."
28. Neergaard, supra note 1, at A9.
29. CONG. REC. S10171, supra note 24. Senator Kennedy also noted that
there is a serious danger that there will be contamination of the device with blood,
respiratory secretions or other body fluids. He cited independent studies that
have shown eighty percent of biopsy forceps were contaminated with blood, tissue
or fecal matter. Id.
30. Id. "When hospitals, or third-party reprocessors, prepare a 'single-use
only' device for use again in another patient, they do not supply the FDA with any
information on the safety and efficacy of the device and they do not notify the
FDA of their intent to remarket the used device." Id.
31. Letter from James M. Jeffords, Chairman, U.S. Senate Committee on
Health, Education, Labor and Pensions, to David M. Walker, Comptroller
General (July 26, 1999) (on file with author).
32. Id. Specifically, the Committee asked the evaluation to include, but not
be limited to, the following questions:
2001]
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On October 26, 1999, H.R. 3148 was introduced by Representatives
Anna Eshoo (D-CA) and Fred Upton (R-MI)." The bill was introduced
"[tlo amend the Federal Food, Drug, and Cosmetic Act to require any
person who reprocesses a medical device to comply with certain safety
requirements and for other purposes. 3 4 The bill includes the following
findings:
FDA data show that reprocessed single-use medical devices
have been associated with serious injury and have the potential
to cause serious injury;"
The devices are being used without patient knowledge,
against the advice of the original manufacturer and without
the FDA's determination that the devices are safe and
effective;36
The reprocessing of single-use devices is occurring without
the required premarket approval or notification to the
FDA;
37
The FDA has the appropriate knowledge and expertise to
evaluate reprocessed devices;
3 8
The only way to protect the public is for the FDA to
enforce the provisions of this Act;39 and
What evidence is there that a threat to public health exists because of the
practice?
What are the current FDA regulations governing reprocessors and to
what extent does the FDA enforce them?
How widespread is the practice, how many devices are reprocessed each
year, and how many different types of devices are being reprocessed?
How many companies currently reprocess single-use medical devices?
What is the economic impact of reprocessing single-use devices, what are
the savings to the hospitals, and what are the potential costs associated
with adverse outcomes linked to the use of reprocessed devices?
What would the cost be if the FDA were required to assure the safety
and efficacy of reprocessed medical devices?
Id.
33. H.R. 3148, 106th Cong. (1999), available at http://thomas.loc.gov/cgi-
bin/query/C?cl06:.?temp?clO6TIDIfu (last visited Jan. 4, 2001). The bill has been
referred to the subcommittee on Health and Environment, available at
[http://thomas.loc.gov] (last visited Jan. 4, 2001).
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The public needs to have assurance that medical devices
are being properly regulated by the FDA so as to guarantee
the safety and effectiveness of the devices. 4°
The purpose of the bill was to
require that the Food and Drug Administration implement and
enforce all provisions of this Act that are applicable to
reprocessed medical devices, including device registration,
listing, and premarket safety controls; and
require the informed consent of patients prior to using
reprocessed class II, class III, and critical class I medical
devices.1
The bill required the Commissioner of the FDA to submit a report to
Congress within nine months of the date of enactment and to describe the
findings from current FDA studies on the safety and efficacy of
reprocessing single-use only medical devices.4' The bill further required
that informed consent be obtained from the patient when such a device is
to be used.43 It also required that a record, as part of the patient's medical
record, be kept by the person or institution that uses such a device.4
On February 10, 2000, the House Commerce Subcommittee on
Oversight and Investigations questioned the FDA Device Center
Director, David Feigal, as to why the FDA "[h]as been slow to take
enforcement action to address the re-use of single-use devices (SUDs). 45
Much of the hearing focused on the new guidelines published by the FDA
that require reprocessors and hospitals that reprocess single-use devices
to meet FDA requirements.4 Feigal said that since the FDA does not
have jurisdiction over the practice of medicine, it cannot intervene when
40. Id.
41. Id. See Hearings on H.R. 3148 Before the Subcomm. on Commerce, 106th
Cong. 106-89 (2000) (statement of Rep. Eshoo) [hereinafter Hearings]. "H.R.
3148 will increase awareness about reprocessed devices by requiring a patient's
informed consent before that single-use medical device is used on them, and by
requiring hospitals to monitor and report injuries or infections that occur as a
result." Id. at 8.
42. Id.
43. Id.
44. Id. The contents of the medical record shall include the name of the
person or business that reprocessed the device, the batch or lot number of the
device, and the identity of the manufacturer of the device. Id.
45. House Panel Grills FDA on Inactivity on Reuse of Single-Use Devices,
FDA WEEK, Feb. 11, 2000, at 3 [hereinafter House Panel].
46. Id.
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hospitals reuse a device. The FDA however, can regulate the
sterilization process, because the reprocessing of the devices turns
481hospitals and reprocessors into manufacturers.
II. RISKS AND BENEFITS OF REPROCESSING
A. Risks of Reprocessing Single- Use Only Medical Devices
Some experts blame the rise in the infection rate on reprocessing and
reuse of single-use medical devices.49 While no one can point to a specific
infection known to be caused by the unauthorized reuse of such devices,
almost two million patients become sick and ninety thousand die from
nosocomial (hospital acquired) infections each year.50 The endoscope, a
device designed for visualizing inside the body and approved for reuse,
has been linked to several known infectious outbreaks.51 Device makers
tell frightening stories, such as the tip of a reused catheter nearly breaking
off in the patient's heart, finding items that have been reprocessed with
traces of blood and bile left on them after reprocessing and finding
forceps with bleach residue remaining on them after cleaning. The risks
of reprocessing also include the potential of adversely affecting the
properties of the device and of failing to remove or destroy every harmful
organism acquired when the device is exposed to the blood stream of the
previous user."
Whenever an invasive procedure is performed on a patient, the most
important factors that protect the patient from infection are the sterility of
the equipment being used and the aseptic technique (e.g., good hand
washing, using sterile equipment, wearing a mask, sterile gloves and gown
and maintaining the sterility of the sterile field) of the health care
practitioner performing the procedure. If the sterility of the equipment is
47. Id.
48. Id. However, the FDA has the authority to inspect reprocessors' good
manufacturing processes (GMPs) and can ensure the integrity of the process.
49. Hawkins, supra note 15, at 67. Proving that a connection between the
reuse of single-use only devices and higher infection rates has been difficult
because of poor patient tracking. Some of the infections can take weeks or
months to develop and often the hospitals are only tracking the patient for twenty-
four to forty-eight hours. Id.
50. Weinberg, supra note 4, at 124.
51. Id.
52. Id.
53. Larry Pilot, Medical Device Manufacturers Association Citizen Petition
to Ban Reprocessed Single Use Device, 10. (May 10, 1999) (on file with author).
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compromised or if there is a break in the aseptic technique of the
practitioner, then the patient is at an increased risk for infection or other
complications.
An FDA study of reused balloon catheters showed that the catheters'
balloons did not always reinflate to the intended size. 4 In cardiac
procedures, the risk to a patient if the balloon over-inflates is that the
balloon could rupture a vessel in the heart and require the patient to
undergo emergency open-heart surgery.5 If the balloon under-inflates,
the physician will have to remove the catheter, causing the patient to
endure a longer procedure and possibly increasing the risk of damage to
the cardiac vessel.
5 6
B. Cost Benefits of Reprocessing Single-Use Medical Devices
Reprocessing and reuse of single-use medical devices may reduce
health care costs for hospitals and can decrease the accumulation of
wastes for disposal.57 The Mayo Clinic reuses single-use only catheters in
its electrophysiology lab and claims that they have not had a single
problem associated with the practice. 8 Stephen Hammill, the director of
54. Hawkins, supra note 15, at 67.
55. Id.
56. Id.
57. Susan V.M. Kleinbeck, et al., Reprocessing and Reusing Surgical Products
Labeled for Single Use, 4 SURGICAL SERVICES MANAGEMENT 21 (1999). For some
single-use medical devices, the cost of meeting the industry standards may
outweigh any potential savings. Hospital managers should not assume that
reprocessing is guaranteed to save money. Id. at 22. Most medical facilities
charge the same price whether a new or reused device is used. In the current
reimbursement system, it is virtually impossible to pass the savings on to the
patient. Id. at 23; Hawkins, supra note 15. Many contend that it is unethical to
charge for a new device when a reused device is used. Id. at 66. But see Hearings,
supra note 41, at 67, testimony of John H. Fielder stating, "But what exactly are
the benefits to the patient? See, this is where we hit the ethical brick wall. The
patient is getting no benefit by being treated with a reprocessed device."
58. Hawkins, supra note 15, at 64-5; Weinberg, supra note 4, at 123. An
electrophysiology catheter is a long, wiry device that is inserted in the patient's
groin and travels through the cardiovascular system to the heart in order to
monitor the patient's cardiac function. Westphal, supra note 9. The cost of two
new cardiac catheters used during an electrophysiology procedure is
approximately $2,000. By using reprocessed or recycled devices, the hospital can
save thirty to fifty percent of the cost. Id. But see Hawkins, supra note 15. Using
a reused angioplasty catheter could potentially save $500, but Jon Resar, Director
of the Catherization Lab at Johns Hopkins Medical Center says, "But that's not
enough to compensate for how unsafe it is." Id. at 66.
2001]
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the lab, estimates that reprocessing has saved his lab about nine million
59dollars over the course of twenty years.
The Association of Medical Device Reprocessors (AMDR), a trade
association in Washington, D.C., claims that reprocessing single-use
devices can result in a fifty percent savings when compared to purchasing
a new device from the manufacturer. 6° Reprocessors maintain that they
are usually able to offer reprocessing for significantly less money than in-
hospital reprocessing and that the reprocessors' sterility is the same or
61better than in-hospital reprocessing.
The claims of monetary savings give rise to many questions. Who is
reaping the benefits? When a patient has a procedure and pays full price
for the new device, is that patient to be reimbursed if the device is
subsequently used on another patient? If the device is used six different
times, is the price shared among the six patients? Will the patient who
received the initial use of the device receive credit if it is used again a few
weeks after the patient is discharged? Are third-party payers, such as
insurance companies, HMOs and Medicare given a discount when the
hospital uses a reprocessed device, and do the third-party payers offer a
reduced premium to their members? How likely is it that hospitals and/or
practitioners will report any incidents that occur when a single-use device
is reused and fails? If the patient does not receive the savings and the
hospital retains the savings, then should the hospital have to make that
fact known to the patient? In Moore v. Regents of the University of
California, the court held that the plaintiff had a cause of action against
the physician for breach of fiduciary duty and lack of informed consent
when the physician failed to inform the plaintiff that the physician had a
financial interest.62
59. Hawkins, supra note 15, at 66. But see Pilot, supra note 53. The claims of
health care cost savings would need to take into consideration any illness or injury
caused by the device, any loss incurred during litigation if the device failed, and
that the reuse of such devices prevents competing manufacturers from decreasing
prices through increase in sales and production. Id. at 19.
60. Association of Medical Device Reprocessors, AMDR and the
Reprocessing Industry 5.
61. Id. But see House Panel, supra note 45. Members of the House of
Representatives raised questions related to the practice of billing the patient the
same amount whether a new or reused device is used and noted that any costs
saved are kept by the hospital. Id. at 3.
62. 51 Cal. 3d 120, 148 (1990).
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1. Proponents' Position
Proponents of reuse say that many of the devices that manufacturers
labeled as single-use only are labeled in that manner because the
manufacturers want to sell more devices." One-third or more of the
hospitals in the United States routinely reuse single-use only disposable
medical devices and defend the practice as prudent and harmless.
64
The AMDR represents third-party reprocessors (as opposed to in-
61hospital reprocessors) of medical devices labeled for single-use only.
AMDR members perform almost eighty-five percent of the reprocessing
done in the United States.66 The AMDR defines a reprocessor as
[An entity that, at the request of a customer, inspects,
functionally tests, cleans, packages, and sterilizes medical
devices labeled for single-use in such a manner that:
The quality, physical characteristics, and performance functions
of the device are not significantly affected,
and
The device remains safe and effective for its appropriate clinical
67use.
The AMDR maintains that its members are committed to complying with
all applicable FDA requirements.8 The association states that the single-
use label is completely arbitrary and that the device makers, not the FDA,
choose when to label a device as single-use only. 69 When discussing the
safety record of AMDR members, the association claims the record is
excellent, with few problems involving the more than nine million devices
that its members have reprocessed. 70 The AMDR claims that the FDA
63. Neergaard, supra note 1.
64. Weinberg, supra note 4, at 123. But see Lisa Scott, Researchers Test Safety
of Medical Devices, MODERN HEALTH CARE, Apr. 24, 1995, at 78. Generally,
hospitals that do not recycle single-use devices fear that the device might fail or
infect a patient the second time it is used.
65. AMDR, supra note 60, at 1.
66. Id.
67. Id.
68. Id. at 2. The AMDR maintains that its members must carry at least five
million dollars in liability insurance and in some cases, the AMDR member carries
at least twenty-five million dollars in liability insurance.
69. Id. at 3.
70. Id. But see Westphal, supra note 9. The lack of adverse reports is easily
explained by a system where the tracking of reprocessed medical devices is poor;
the reports will frequently register as a problem with the actual device without
noting that the device was reprocessed. Neither the hospital nor the physician
20011
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regulates third-party reprocessors, who must register with the FDA. 1 The
AMDR also maintains that reprocessors must adhere to all applicable
Quality System Regulation requirements, and reprocessors must be in•71
compliance with Medical Device Reporting Regulations requirements.
The AMDR does not advocate the reprocessing of every single-use
only medical device, and reports that only a small percentage of the
devices used by hospitals are reprocessed.73 Indeed, "AMDR's guiding
principle is that a device should only be reprocessed if it can be
scientifically proven and validated that the device can be cleaned,
functionally tested, sterilized, and reused without harm to the patient.
74
However, independent, peer-review studies related to the practice of
reusing disposable medical devices are rare.7 ' The few studies that have
been done have not been substantial enough to conclude whether or not
76reprocessing is safe.
2. Opponents' Position
Many hospitals and physicians are concerned about reusing single-use
only medical devices. Dr. J.P. Abenstein, Chairman of the Equipment
Subcommittee at the Mayo Clinic, explains that most disposable devices
become contaminated with fluids such as blood, urine, and saliva, and that
these devices were not meant to undergo resterilization.7 ' Dr. Abenstein
states, "Given the fairly convincing literature that high temperatures and
caustic chemicals change the nature of the materials, I'd be leery of
reusing disposable (devices)."78
HIMA is a Washington, D.C. trade association that represents more
follows the patients after the reused device has been used. When a complication
or problem occurs, it can appear that something other than the device caused the
complication or problem. Id. at Al.
71. AMDR, supra note 60, at 4.
72. Id.
73. Id. at 5.
74. Id.
75. See Westphal, supra note 9. The article points out, "Other analyses
abound that tend to incriminate or absolve the practice of reprocessing - but these
are mostly sponsored by manufacturers or reprocessors, and the results tend to
support the sponsor's point of view." Id.
76. Id.
77. Weinberg, supra note 4, at 124.
78. Id. France has banned reusing single-use only disposable medical devices.
In Australia, a physician conducted a survey and concluded that approximately
forty percent of hospitals reuse disposable devices, and that thirteen of the
fourteen most commonly recycled devices were unsafe. Id. at 125.
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than seven hundred manufacturers of health care products and medical
devices."9 HIMA has adopted principles pertaining to the reuse of single-
use devices which include: Supporting the right of the manufacturers to
design and label devices for single-use only; opposing promotion of the
reuse of devices that were designed and/or labeled for single-use;
opposing efforts by government regulatory authorities' to require that
manufacturers of single-use devices test or label those medical devices for
multiple uses; and asserting that the FDA must exert its regulatory
authority over reprocessors of single-use devices. 8 HIMA maintains that
manufacturers have longstanding concerns related to the practice of
reusing single-use medical devices that include product quality, product
81safety, and product liability.
The Medical Device Manufacturers Association (MDMA), a
Washington, D.C. trade association, represents approximately 130
medical device manufacturers. 2 MDMA claims that the decision to label
a device for single-use only is based on whether or not the manufacturer
determines its device would expose a second patient "[t]o an
unreasonable and substantial risk of illness or injury." 3 The manufacturer
must also make a determination whether or not it can guarantee that its
device can be restored to the original condition.8 MDMA states, "The
properties of the single use device can be materially altered during the
initial use to the extent that the device may not meet the release
acceptance criteria of the original finished device manufacturer.
8 1
III. INFORMED CONSENT
Patients must trust their physicians and other health care professionals
to tell them of the risks involved with medical procedures, treatments and
79. HIMA, supra note 7, at 1.
80. Id.
81. Id.
82. Pilot, supra note 53, at 1. Many of these manufacturers make medical
devices that are intended for single-use only. Id.
83. Id. at 9.
84. Id. at 10.
85. Id. at 15. An FDA evaluation of reused percutaneous transluminal
coronary angioplasty (PTCA) catheters showed that reprocessing changed the
characteristics of some of the catheters. Id. The petition states in part, "Although
the user facility is required to report such events (failure of the device) to the
FDA in accordance with the Medical Device Reporting (MDR) regulation, 21
C.F.R. Part 803... The objective of this petition is to prevent the occurrence of a
single event." Id. at 16.
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86care through the informed consent agreement. However, patients are
not told when medical devices have been used in other patients, or that
these devices were manufactured and designed to be used only once.87 A
recent poll of five hundred people in the United States found that a vast
majority felt "[a]ngry, frightened and betrayed" by the idea that they or a
loved one might be subject to increased health risks related to the practice
of reusing single-use only medical devices.
Congress and the FDA are not alone in examining the issue of reusing
single-use devices. Illinois and Florida are attempting, with limited
success, to regulate reprocessed medical devices by requiring informed
89consent from patients before such devices can be used.
Even if the reprocessor can guarantee that a reused device is identical
to the manufacturer's original specifications, the patient should give
informed consent for the use of the device.9 Obtaining such informed
consent creates a number of problems: the original manufacturer is no
longer the manufacturer and cannot be identified with the device; liability
of the original manufacturer must be waived and the reprocessor must
accept the liability; and the patient should be informed of the health
status/risk of the prior patients on whom the device had been used. 91
Some of a patient's pertinent medical history, such as HIV status, may not
be known to the health care professional who uses the device on the first
patient. Therefore, that information would not be available to be passed
on to the next patient who is having a procedure with the same device. In
order to accurately and fully obtain all pertinent information, the patient
on whom the device is initially used would have to provide detailed
information that the patient has a right to keep private.
86. Lockhart, supra note 5, at 44.
87. Id. at 42.
88. Id. at 44. The results of the survey indicate that consumers had concerns
that the device would be damaged by excessive cleaning, and were concerned
about the possibility of device contamination. Almost ninety percent of those
surveyed would choose a hospital with a policy against reusing single-use devices,
and would be angry upon being billed for a new device when a reused one had
been utilized. Thirty-nine percent of the people in the survey said they "[wiould
consider buying their own new medical devices." Id.
89. Chad Terhune, Legislator Wants Hospitals to Stop Reusing Devices, WALL
ST. J., Nov. 24, 1999. Florida State Rep. Bob Henriquez wants to ban the reuse of
medical devices because of the risks of infection, injury and mechanical failure. If
his bill passes, violators could be sentenced for up to sixty days in jail and fined
$500. Id.
90. Pilot, supra note 53, at 13.
91. Id.
Single- Use Medical Devices
Southard v. Temple University Hospital addressed the issue of informed
consent for medical treatment.92  Southard involved a coordinated
litigation with numerous plaintiffs and defendants.93 In Southard, the
plaintiff brought a malpractice action claiming that the defendant
physician and hospital had failed to obtain informed consent. 94 The
plaintiff's claimed the defendants had not advised the plaintiff that the
FDA had classified the bone screws used in his surgery as a Class III
medical device under the Medical Device Amendment Act, when used in
the spine.9' The plaintiff appealed the grant of partial summary judgment
to the physician and hospital as to the defendant's failure to inform the
plaintiff of the FDA classification. 96 The appellate court found that the
lower court erred in granting partial summary judgment.9
The court in Southard explained that Pennsylvania's informed consent
doctrine is based on the "prudent patient" standard.98 Therefore, the
issue of informed consent must be viewed from the perspective of the
patient.99 For informed consent to be adequate, the patient must be
informed of "[m]aterial facts, risks, complications and alternatives to
surgery, which a reasonable man in the patient's position would have
considered significant in deciding whether to have the operation."1°° The
court went on to say, "In an informed consent action, the relevant inquiry
92. 731 A.2d 603, 1999 Pa. Super. 95 (1999).
93. Id. at 608.
94. Id.
95. Id. at 608; GEORGE D. POZGAR, LEGAL ASPECTS OF HEALTH CARE
ADMINISTRATION (1999). The law imposes a duty for physicians "[t]o disclose
known and existing dangers associated with a specific course of treatment." Id. at
207; see Leggett v. Kumar, 570 N.E.2d 1249 (1991). A physician has a duty to
adequately inform a patient of the risks associated with surgery. Id. at 1262.
96. Southard, 731 A.2d at 609.
97. Id. at 612.
98. Id. at 610.
99. Id.
100. Id. (quoting Gouse v. Cassell, 615 A.2d 331, 333 (1992)). See 40 P.S. §
1301.103 (amended 1996) as interpreted by the court, 40 PA. STAT. ANN., 1301.103
(West 1999).
Informed consent means.., the consent of a patient to the performances
of health care services by a physician ... [p]rovided ... [t]hat[,] prior to
consent having been given, the physician ... has informed the patient of
the nature of the proposed procedure or treatment and of those risks and
alternatives to treatment or diagnosis that a reasonable patient would
consider material to the decision whether or not to undergo treatment or
diagnosis.
731 A.2d at 610, n.9.
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is whether a prudent patient would consider significant a particular fact,
risk, complication or alternative to a surgical procedure; if so, that
information must be disclosed."' ' 1 The court also said that it believed that
a prudent patient would want to know whether or not the FDA had
approved a medical device as safe and effective for a particular use when
deciding whether or not to give consent for a surgical proce0ure.
Extending the Southard rationale to the immediate issue causes one to
ask whether a prudent patient would want to be informed whether the
medical device being used on him had been used before, and whether that
device was manufactured and labeled for single-use only. Any
hospitalization that requires an invasive procedure has some inherent
risks that cannot be completely eliminated. A patient undergoing such a
procedure is informed of the risks, informed of the benefits, informed of
alternatives, and then makes an informed decision whether or not to have
the procedure or surgery performed. It is safe to assume that most
patients prefer the procedure or surgery to be performed with the lowest
possible risk. By inference, most patients would not want to increase
their risks unnecessarily by allowing a reused medical device to be used
on them when that device was not manufactured, marketed or approved
for more than a single-use.
101. Southard, 731 A.2d at 612.
102. Id. But see Klein v. Biscup, 673 N.E.2d 225, 231 (1996), holding
"fa]ccordingly, we conclude that failure to disclose FDA status does not raise a
material issue of fact as to informed consent." Id. The court noted that the off-
label use of a medical device is not a risk of a therapeutic procedure, noting the
FDA does not regulate the practice of medicine. Id. See also Pennsylvania
Appeals Court: Guaranty Fund Entitled to Setoff in Malpractice Case, 4 MEALEY'S
EMERGING DRUG & DEVICES, Dec. 3, 1999, at 17.
In a suit for medical malpractice, a jury found doctors liable on the issue of
informed consent because the doctors failed to advise the plaintiff that the bone
plates and screws were new and experimental in nature. Id. The court's decision
in Southard is the only decision holding that a patient needs to be told of the
FDA's classification. See Mark Herrmann 'Single Use' Medical Devices: Tempest
in a Teapot, 4 MEALEY'S EMERGING DRUGS & DEVICES, Dec. 3, 1999 at 20, 22;
Earle v. Ratliff, 998 S.W.2d 882 (1999), Hansen v. Universal Health Services Inc.,
974 P.2d 1158, 1159, (1999), Alvarez v. Smith, 714 So2d 652, 65-4 (1999). The
court in Alvarez said, "Regarding the FDA status, the majority of reported cases
hold that as a matter of law doctors are not required to disclose the FDA status of
pedicle screws because such status is not a medical risk of surgery." Id. The
Pennsylvania Supreme Court has a petition for allocatur pending to review the
decision in Southard. Herrmann, supra at 22.
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IV. THE ETHICS OF EXPERIMENTATION
John Fielder, a bioethicist and expert on reuse says the practice of
medical device reuse is "[m]edical experimentation without benefit,
written consent - or even patient knowledge."'' 3 There are many official
policies that govern medical research using human subjects.'9 The
principles articulated by the Nuremberg Code require "[t]hat there be
informed consent from the subject before the experiment begins and
during the continuation of the experiment and the requirement that there
be appropriate benefits and risks."' ' The latter requirement means that
the amount of harm to the patient should be minimized and that the
potential benefits should be sufficient to outweigh the harms that are
associated with the research.'O° In the United States, the FDA regulates
medical experiments and requires advanced approval of most medical
research by independent committees called Institutional Review
Boards."'° Some forms of research on human subjects can be performed
legitimately without informed consent from the patients, such as chart
reviews and interviews, because they seem to pose few risks to the
patient. Informed consent is not always required in emergency
situations when there is neither the time nor a competent patient to give
informed consent. 109
The regulation of medical devices was not seriously undertaken by the
FDA until the mid-1970s." ° Under current statutory authority the FDA
103. See Hawkins, supra note 15, at 63.
104. BARUCH A. BRODY, THE ETHICS OF BIOMEDICAL RESEARCH 33 (1998).
105. Id. at 33, 34; See also S. SANDY SANBAR, et al., LEGAL MEDICINE 631
(1998). The Nuremberg Code states:
The voluntary consent of the human subject is absolutely essential. This
means that the person involved should have legal capacity to give
consent; should be so situated so as to exercise free power of choice,
without intervention of any element of force, fraud, deceit, duress,
overreaching, or other ulterior form of constraint or coercion, and should
have sufficient knowledge as to enable him to make an understanding
and enlightened decision ... The duty and responsibility for ascertaining
the quality of consent rests upon the individual who initiates, directs or
engages in the experiment. It is a personal duty and responsibility which
may not be delegated to another with impunity. Id. at 631.
106. BRODY, supra note 104, at 34.
107. Id. at 35.
108. Id. at 38.
109. Id. at 39.
110. Id. at 164. See also Medical Device Amendment (1976); THOMAS J.
DUESTERBERG, et al., HEALTH CARE REFORM, REGULATION AND INNOVATION IN
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has placed medical devices in three classes: Class I, Class II, and Class III
devices."' Class I devices are not required to meet any standards or to
obtain premarket approval. Class II devices must meet certain/ 114
standards."' Class III devices require premarket approval by the FDA."4
The FDA generally requires clinical testing before a device can be
marketed."' Clinical testing or experimentation needs to be conducted in
order to determine the safety and efficacy of reusing single-use only
medical devices. Little literature is available regarding medical research
on the reprocessing of single-use devices. One study, performed in.* . 116
Quebec, Canada, examined the reuse of angioplasty catheters. The
initial results of the study suggested that the rate of complications
increased in the hospital that reused catheters."' However, the
investigators found significant differences that could account for the
increased complications without blaming the reused catheters."' Other
established risk factors, such as the severity of the underlying pathology in
the patients studied, were independent predictors of adverse outcomes."9
When the study was reanalyzed, comparing only inpatients with stable
angina, there was essentially no difference in outcomes of the patients in
which the catheters had been used only once and those in which the
THE MEDICAL DEVICE INDUSTRY 75 (1994). "The 1976 amendments to the Food
and Drug Act established the basic regulatory framework for the device industry,
but as would quickly become clear, they did not resolve the basic question of how
to protect the public health and safety through effective regulation of the
industry." Id.
111. BRODY, supra note 104, at 164; 21 U.S.C. § 360c (1997) Classes of
devices; § 360(c)(a)(A) Class I, General Controls; § 360(c)(a)(B) Class II, Special
Controls; and § 360(c)(a)(C) Class I1, Premarket Approval.
112. BRODY, supra note 104, at 164; DUESTERBERG, supra note 110, at 75-6.
"Class I devices are those with minimal risk, such as cotton swabs, tongue
depressors and bandages." Id.
113. BRODY, supra note 104, at 164; DUESTERBERG, supra note 110, at 76.
"Class II devices were defined as those with intermediate risk, such as syringes,
hearing aids, anesthesia-delivery machines, and electrocardiac machines." Id.
114. BRODY, supra note 104, at 164; DUESTERBERG, supra note 110, at 76.
"Medical devices in the highest risk category, classified by the FDA as Class III
devices, included implantable devices and life-sustaining equipment." Id.
115. BRODY, supra note 104, at 164.
116. Koon-Hou Mak et al., Absence of Increased In-Hospital Complications
with Reused Balloon Catheters, 78 AM. J. CARDIOLOGY 717 (1996).
117. Id. at 718.
118. Id.
119. Id.
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catheters had been reused. 12 The authors of the article acknowledged the
limitation of their study and said, "It would be reassuring if these results
are corroborated by other randomized studies that are being planned in
Canada and in the United States.'
12'
A second study reported in the Journal of the American Medical
Association (JAMA) examined the effect of dialyzer reuse. The study
reported higher mortality in dialysis facilities that reprocessed dialyzers
than in facilities not reprocessing dialyzers. While the study was unable
to determine whether the reprocessing of the dialyzers or other factors
caused the higher morbidity rate, the findings raised significant concerns
about "[plotentially avoidable mortality among US hemodialysis patients
treated in dialysis facilities reprocessing hemodialyzers.
1 24
Canadian researchers performed a third study to determine whetheree • 125
reuse of disposable laparoscopic instruments was safe and cost effective.
The study determined that, "Under carefully monitored conditions and
strict guideline reuse of disposable laproscopic and thoracoscopic (used to
visualize the internal condition of the lungs) instruments can be cost-
effective.'
126
When discussing the practice of reusing single-use devices, Larry
Spears, a senior compliance official with the FDA, said "There isn't [sic]
120. Id.
121. Id.; Martial G. Bourassa, The Reuse of Single-Use Balloon Angioplasty
Catheters: Is It Now Legitimate?, 78 AM. J. CARDIOLOGY 673 (1996). Stating that
new data lend some support and reassurance to centers that are currently
continuing the practice of reusing angioplasty catheters. Id. at 674.
122. Harold I. Feldman et al., Effect of Dialyzer Reuse on Survival of Patients
Treated with Hemodialysis, 276 JAMA 620 (1996).
123. Id.
124. Id.
125. Jean-Gaston Des Coteaus, et al., Reuse Laparoscopic Instrument; A
Study of Related Surgical Complications, of Disposable, 38 CAN. J. OF SURGERY
497 (1995). The article states "Under the circumstances described in this paper,
reuse of disposable instruments may offer part of the solution to the problems of
fiscal restraint and allow medical caregivers access to state-of-the-art technology
at a reduced cost without compromising the quality of patient care." Id. at 500.
126. Id. at 497. See S. K. Roach et al., In Vitro Evaluation of Integrity and
Sterilization of Single-Use Argon Beam Plasma Coagulation Probes, 94 AM. J. OF
GASTROENTEROLOGY 139 (1999) (finding that argon coagulation probes,
marketed for single-use only, can potentially be safely and effectively reused up to
ten times and that a significant saving is possible). Argon coagulation probes have
been approved for use in the United States for the treatment of gastrointestinal
bleeding. Id. at 139.
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data to show that this is a safe practice."'' 7 If, as Dr. Fielder suggests, the
reuse of single-use medical devices constitutes experimentation, the
practice is not being properly monitored as required by the FDA. While
reuse of single-use medical devices carries risks for the patient, the
practice holds no benefits for the patient. In order to justify such
experimentation, the patient must benefit in some manner from the
experiment. The concern raised by Dr. Fielder needs to be addressed as
yet another unresolved issue surrounding the controversy.
V. OTHER ISSUES IMPLICATED BY THE REUSE OF SINGLE-USE
ONLY MEDICAL DEVICES
A. Warranties and Product Liability
"Strict liability (i.e., not negligence based) is imposed on
manufacturers, sellers, and distributors of unreasonably dangerous and
defective products for injuries resulting from their use.",' 28  When a
manufacturer places a product into the marketplace, it guarantees that the
product is safe and effective if used properly. To recover under a cause of
action based on a breach of warranty, the plaintiff must first establish
whether the warranty was express or implied. 29 The manufacturer of a
product makes an express warranty when it includes specific promises or
affirmations to the buyer.3 Implied warranties "[alre in effect when the
law implies that one exists by operation of law as a matter of public policy
for the protection of the public."'' The original manufacturer of a single-
127. Scott Heneley, Eyeing the Reprocessors, MODERN HEALTH CARE, Sept.
23, 1997, at 64.
128. POZGAR, supra note 95, at 64.
The following elements must all be present for a plaintiff to proceed with
a case based on the basis of strict liability:
The product must have been manufactured by the defendant.
The product must have been defective at the time it left the hands of the
manufacturer or seller. A defect in the product, and/or an absence or
inadequacy of warning for the use of the product.
The defective product must have been the proximate cause of injury to
the plaintiff.
Id. If a medical device fails, the manufacturer can be held strictly liable if the
product was defective and the defect was the proximate cause of the patient's
injuries. Id.
129. Id. at 63.
130. Id.
131. Id.
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use medical device makes both express and implied warranties.
"Reprocessing single-use products negates the manufacturer's
warranties and could interfere with the original function of the
product." '132 If a hospital or medical facility performs the reprocessing, it
assumes liability if the device fails to perform properly."' If a hospital or
medical facility contracts with a reprocessing company, liability will
depend upon the warranty provided by the reprocessor. 34 Dr. Larry
Spears said that when hospitals reuse single-use medical devices, "They
go beyond the intended use on the label-and at their own risk." '35
It is easy to envision what would happen if a reprocessed device failed
and caused serious injury to a patient. The manufacturer would deny any
liability because the device was designed, manufactured and labeled for
single-use only. The reprocessor would deny liability and blame the
manufacturer for a defect in the product. The hospital would deny
liability and place the blame on the manufacturer or reprocessor. The
insurance companies, very likely, would claim not to be liable because the
hospital or reprocessor violated the FDCA.
B. Patent and Trademark Infringement Issues
The FDA regulates medical devices, many of which are patented by the
manufacturer. One such manufacturer brought an action for patent
infringement and inducement to infringe against a reprocessor of medical
devices in Mallinckrodt Inc. v. Medipart Inc.136 In that case, Mallinckrodt,
the manufacturer, sold its patented product to hospitals. The hospitals
used the device, sent it to Medipart for servicing, then reused the device. 37
In reversing summary judgment for the reprocessor, the appellate court
said, "[Ulse in violation of a valid restriction may be remedied under the
patent law, provided that no other law prevents enforcement of the
132. Kleinbeck, supra note 57, at 21.
133. Id. See generally Janice M. Hogan & Thomas E. Colonna, Products
Liability Implications of Reprocessing and Reuse of Single-Use Medical Devices, 53
FOOD AND DRUG L. J. 358 (1998). The authors state, "[p]roduct recondition to
extend useful life is more likely to support a strict liability claim than is mere
repair or maintenance that does not demonstrably impact useful life." Id. at 394.
In the event of device failure, reprocessors may be liable for breaches of implied
or express warranties. Id. at 400.
134. Kleinbeck, supra note 57, at 21.
135. Id. at 23.
136. Mallinckrodt, 976 F.2d. 700 (1992).
137. Id. at 701.
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patent."'38 The court explained that the enforceability of a restriction on
the use of patented products was derived from the patent grant, which
includes, under property terms, the right to exclude. 9 However, the
holder of the patent may waive this right to exclude. 40 Quoting United
States v. General Electric Co., the court said "The patentee may grant a
license upon any condition the performance of which is reasonably within
the regard which the patentee by grant of the patent is entitled to
secure."' 141 In remanding the case, the appellate court held that the district
court erred in holding that the restriction on reuse was unenforceable and
found that if the restriction on reuse was within the scope of the patent,
then an action for patent infringement could be valid l.4
There is a growing trend among hospitals to send medical devices out
for unauthorized repair. This includes remanufacturing of the medical
device .14' Karl Storz manufactures endoscopes for use by hospitals, which
send them to unauthorized companies for repair, often using nongenuine
components. 144 Storz is seeking a court order requiring a repaired
endoscope to bear a "[p]ermanent label indicating that a repair has been
made, and by whom and with respect to rebuilt scope, that labeling is not
sufficient so that the repair shops remove all of Karl Storz's trademarks,
thus alerting the user that it is no longer a Karl Storz product.' ' 45 Storz
believes that by leaving the name "[o]n the remanufactured products it
creates the completely false and potentially dangerous impression in the




139. Id. at 703. The statute in question, 35 U.S.C.A. § 154(a)(1), P.L. 106-274
(2000) states:
Every patent shall contain a short title of invention and a grant to the
patentees, his heirs or assigns, of the right to exclude others from making,
using, offering for sale, or selling the invention throughout the United
States, and if the invention is a process the right to exclude others from
using, offering for sale or selling throughout the United States, or
importing into the United States, products made by the process, referring
to the specification for the particular thereof.
140. Mallinckrodt, 976 F.2d at 703.
141. Id. at 704.
142. Id. at 709.
143. Gail Dearing, Hazards of Remanufacturing Medical Devices,
BIOMEDICAL MARKET NEWSLETTER, Jan. 31, 2000, at 40.
144. Id. at 41.
145. Id. at 43.
146. Id.
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Courts have repeatedly ruled that the manufacturer of a product has
the "[r]ight to control the manufacturing process and quality of products
bearing its trademark .... The wrong inheres in involuntarily entrusting
one's business reputation to another's business."'
147
By analogy, any single-use medical device that is reprocessed for reuse
will usually retain the trademark of the original manufacturers. The
physicians and nurses who use the products rely on the reputation of the
products and their knowledge of the reliability of the products based on
prior experience. If the health care team is unaware that the device had
been reprocessed, the team may be placing its confidence in an
undeserving device.
C. Adulteration and Misbranding
It is unlawful in the United States to distribute or import articles that
are misbranded or adulterated. The term "adulterated" refers to
articles that are defective, unsafe, or manufactured under unsanitary
conditions.149 "Misbranding" includes statements and designs in labeling
that are misleading or false, as well as the manufacturer's failure to label
the product with information required by law."O "Consequently, any
reprocessing of a previously used single use device for reuse results in
misbranding and adulteration of the device for which the violations under
the FDCA are quite clear."''
VI. THE FOOD AND DRUG ADMINISTRATION
The MDMA submitted a petition on May 20, 1999, requesting the
Commissioner of the FDA "[t]o issue a proposed regulation identifying
reprocessed single use devices as banned devices and declaring such
proposed regulation to be effective upon its publication in the Federal
Register (F.R.)."'' 12  In its petition, the MDMA contends that the
manufacturers of certain medical devices are required by the FDA to
label those devices for single-use only. 153 The MDMA also states that
such devices cannot be reused because information has not been offered
to the FDA to show that reprocessing of the device will not impair its
147. Id.
148. 21 U.S.C. § 342, 351, 361 (1994); SANBAR, supra note 105, at 588.
149. 21 U.S.C. § 343, 352, 363 (1994); SANBAR, supra note 105, at 588.
150. SANBAR, supra note 105, at 588.
151. Pilot, supra note 53, at 13.
152. Id. at 1.
153. Id.
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safety or effectiveness.
The FDA has the authority to ban medical devices if the use of the
device presents substantial deception or an unreasonable risk of illness or
injury."' The 1976 Medical Device Amendment described the criteria and
procedure necessary to identify a banned device."' The criteria require a
finding that a medical device presents an unreasonable risk of injury or
illness before proceedings to ban a device can be initiated9
Manufacturers of medical devices are ultimately responsible for
deciding whether a device is reusable or not. 8 In making that decision,
manufacturers are understandably cautious, because any unnecessary risk
to the patient is an unacceptable risk. I 9 If the FDA determines that a
device cannot be reused safely, the FDA can require that the device be
labeled for single-use only.'6 The MDMA petition submits that the
hospitals and reprocessors "[a]re processing/reprocessing and distributing
single use devices for reuse with no knowledge of the final release
acceptance criteria applied by the original single use device
manufacturer."161
On October 6, 1999, the FDA denied the petition requesting a ban on
the reuse of single-use medical devices. In its denial, the FDA found that
154. Id. at 4.
155. FDCA § 516, Pub. L. No. 75-717, 52 Stat, 1040 (1938) (codified as
amended 21 U.S.C. §§ 310 et seq. (1994)).
156. Pilot, supra note 53, at 6.
157. Id. FDCA § 516, 21 U.S.C. § 360 (f)(1994).
General rule-Whenever the Secretary finds, on the basis of all available data and
information that-
a device intended for human use presents substantial deception or an
unreasonable and substantial risk of illness or injury in the case of
substantial deception or an unreasonable and substantial risk of illness or
injury which the Secretary determined could be corrected or illuminated
by labeling or change in labeling and with respect to which the Secretary
provided written notice to the manufacturer specifying the deception or
risk of illness or injury, the labeling or change in labeling to correct the
deception or eliminate or reduce such risk, and the period within such
labeling or change in labeling was to be done, such labeling or change was
not done, such period: he may initiate a proceeding to promulgate a
regulation to make such a device a banned device.
Id.
158. Pilot, supra note 53, at 9.
159. Id. at 10.
160. Id. at 11.
161. Id. at 12.
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"There is no clear evidence that reprocessing presents an unreasonable
and substantial risk of illness or injury, which is one of the criteria for
banning a medical device." '162 The FDA, in its denial, acknowledged that
it had received "[a]dverse event reports where a reprocessed single use
device was involved; however, in each of those cases, it was not clear that
reprocessing caused the problem reported." '163 Although the FDA did not
ban the reprocessing of medical devices, it said "Significant reevaluation
of FDA's position with regard to reuse of single use devices is in order."'
1
On October 21, 1999, the MDMA petitioned the FDA for reconsideration
of its petition to ban the reprocessing of single-use devices. 16 The petition
for reconsideration states:
1) The petition demonstrates that relevant information or views
contained in the administrative record were not previously or
adequately considered.
2) The petitioner's position is not frivolous and is being pursued
in good faith.
3) The petitioner has demonstrated sound public policy grounds
supporting reconsideration.
4) Reconsideration is not outweighed by public or other public
interest - to the contrary, public health and public interest
justify the need for the FDA to prevent unequivocal
adulteration and misbranding of single use devices rather than
act after death or serious injury has occurred. 166
In enacting the Medical Device Amendment, Congress established the
means by which the FDA can regulate the manufacturing and sale ofS • 167
medical devices. Medical devices are classified, inter alia, by the
regulatory controls necessary to provide reasonable assurance of safety
and effectiveness. The FDA requires Class I devices to meet certain
162. Letter from David W. Feigal Jr., Director, Center for Devices and
Radiological Health, FDA, to Larry R. Pilot, Counsel to Petitioner, Medical
Device Manufacturer Association (Oct. 6, 1999) (on file with author).
163. Id.
164. Id.
165. Larry R. Pilot, Petition for Reconsideration, Oct. 21, 1999, at 1 (on file
with author).
166. Id. at 4.
167. 21 U.S.C. §§ 351-360ss (1995), 21 C.F.R. Parts 800-899 (Revised 1994).
168. Medical Device Amendment Act, 21 U.S.C. § 360(c) (1994). General
controls are those used for devices that do not support or sustain life. Special
controls are for devices that are not classified as Class I devices and general
controls are insufficient to provide reasonable assurance of safety and
effectiveness. Premarket approval is for devices that are used to support or
20011
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registration and record keeping requirements (general controls); for Class
II devices, the FDA requires the manufacturers to comply with standards
and maintain patient registries (special controls); and for Class III devices
the FDA requires that the manufacturer complete a rigorous application
process and receive FDA approval prior to marketing the device
(premarket approval).1
69
Reprocessing is being performed by both third-party reprocessors and
hospital in-house facilities. 7°  Approximately one million devices are
reprocessed each year, resulting in a burgeoning reprocessing industry
that services the needs of one-third of the hospitals in the United States.
17
In the next year, the reprocessing industry expects sales to double and
estimates that hospitals are resterilizing and reusing far more devices than
172the reprocessors make available for reuse.
Currently, if a manufacturer of a disposable device wants to change the
label from single-use to reusable, the manufacturer is required by the
FDA to submit documentation, called "premarket notifications"
demonstrating that the change in labeling and use of the device is safe.'73
However, reprocessors are not required to adhere to similar
documentation requirements, even though the reprocessors essentially
change the single-use device to a reusable device. Manufacturers
contend that many reprocessors are not even registered with the FDA,
and that of the estimated twenty-three reprocessors, only seven are
actually registered as required by the FDA. 
7
The FDA leaves the decision of whether or not to reuse single-use only
medical devices up to the hospital, but it says hospitals that reuse
disposable devices are liable for the safety and effectiveness of the
product. 76 The Original Equipment Manufacturer (OEM) is subject to
sustain human life or those of substantial importance in preventing impairment of
human health. Id.
169. 21 U.S.C. § 360(a)(1)(A)-(C), 21 C.F.R. Part 860 (1994).
170. Westphal, supra note 9, at Al; Weinberg, supra note 4. The FDA
requires outside reprocessors to register with the FDA, but it acknowledges that
not all reprocessors are registered and the FDA does not know how many are in
the business. Id. at 123.
171. Westphal, supra note 9, at Al.
172. Weinberg, supra note 4, at 124.
173. Westphal, supra note 9, at Al.
174. Id.
175. Id. The article states, "FDA registration for reprocessors, however is
essentially voluntary... That registration loophole could allow shady operators to
go undetected and uninspected by the FDA." Id.
176. Scott, supra note 64, at 78.
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requirements of the Federal Food, Drug and Cosmetic Act (FDCA),
including registration, premarket notification, approval requirements,
submitting adverse event reports under the Quality Systems Regulation,
labeling requirements, Medical Device Tracking and Medical Device
Corrections and Removals."' Hospitals that do in-house reprocessing are
required to ensure that the devices are adequately cleaned and sterilized,
in addition to maintaining safety, effectiveness and quality of the device."'
Currently, third-party reprocessors are subject to registration, listing
quality systems regulations, medical device reporting regulations and
premarket requirements. "9 The FDA has issued warning letters to third-
party reprocessors for a number of violations, including failure to comply
with quality system requirements, failure to validate sterilization
procedures and failure to label the devices with adequate directions for
use.18 The FDA has not regulated the OEMs, the third-party
reprocessors and the health care facilities in a consistent manner with
regard to single-use devices.
The FDA is currently in the process of reevaluating its position on the, 182
reuse of single-use medical devices. The agency maintains that its
primary goal is "[tjo protect the public health by assuring that the practice
of reprocessing and reusing SUDs is based on good science. 183  To
accomplish this goal, the FDA held an open meeting in Rockville,
177. 21 C.F.R. Parts 801-814 (revised 2000).
178. U.S. Dept. of Health and Human Services, Food and Drug
Administration, Center for Devices and Radiological Health: Public Comment,
available at http://www.fda.gov/cdrh (last visited Nov. 3, 1999) [hereinafter Public
Comment].
179. Id. at 4.
180. Id. at 5; Letter from Douglas D. Tolen, Director, Florida District, FDA
to Rick Ferreira, CEO, Alliance Medical Corporation, Dec. 23, 1999 (on file with
author). The FDA cited a reprocessor for six violations including failure to
establish a quality policy as required by law, failure to establish and maintain
procedures to ensure device history records are maintained, failure to adequately
document cleaning and maintenance of the facility and process equipment, and
three other violations. Id.; Letter from Edward R. Atkins, Acting Director
Florida District, FDA to Louis L. Rudt, President, Visions in Endosurgery, Inc.,
Jan. 6, 2000 (on file with author) (citing seventeen violations by the reprocessing
facility).
181. U.S. FDA Executive Summary, Open Meeting: Proposed Strategy on
Reuse of Single-Use Devices, at 1, available at
http.www.fda.gov/cdrh/reusel2l4execsum.html (last visited Feb. 2, 2000)
[hereinafter Open Meeting].
182. Id. at 1, 2.
183. Public Comment, supra note 178, at 7.
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Maryland, on December 14, 1999, in order to obtain information from
interested parties on its proposed strategy on the reuse of single-use
devices.'9
Following the open meeting, the FDA created a list of issues that
needed to be addressed before a comprehensive regulatory strategy could
be implemented." 5 This list includes: Clarification of the FDA action
plan; sterility validation guidance; guidance on registration for health care
facilities; developing an auditing program; regulating labeling of single-
use devices; and use of quality systems with reused medical devices.1
86
The FDA acknowledged the need to change the manner in which reuse of
single-use medical devices has been regulated. 187 The FDA believes that
there are medical devices whose reuse probably poses significant risk to
the public. ""
In February 2000, the FDA said "it will begin requiring both hospitals
and third parties that reprocess single-use devices (SUDs) to meet the
same premarket approval and other FDA requirements traditionally
applied to SUDs.' 8 9 Reprocessors and hospitals will be allowed six
months to meet all applicable requirements for "high risk" SUDs, twelve
months for devices that are "moderate risks" and eighteen months to
meet requirements for "low risk" medical devices.90
CONCLUSION
The FDA missed an opportunity to fulfill its mandate and to protect
the health of the American public. The FDA should consider banning the
use of reprocessed medical devices until sufficient scientific data are
available to show that the practice is safe and effective. Instead, the FDA
is essentially allowing the practice to continue until it is proven unsafe. In
the meantime, patients' health and lives are being put at risk
unnecessarily.
Reprocessing and reusing single-use only medical devices may be a
safe, harmless and cost effective alternative to expensive new devices. If
the practice continues, OEMs will not be able to bring down the costs of
new devices. Rather, costs are likely to increase to cover expenses and
184. Open Meeting, supra note 181.
185. Id. at 5.
186. Id.
187. Id.
188. Id. at 1.
189. House Panel, supra note 45, at 4.
190. Id.
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development in manufacturing. However, at the current time, too many
questions remain regarding the safety and efficacy of the practice.
Legitimate concerns related to the lack of informed consent have not
been addressed. If informed consent were required, undoubtedly all but a
few patients would agree to the risks associated with the reused medical
devices. The question that consumers need to ask is whether they would
want such a device used on themselves or on their loved ones.
Before the practice should be allowed to continue, extensive medical
and clinical research needs to be conducted to determine whether or not
the practice is safe. Then each transformed or reprocessed device would
need to receive FDA approval.
No data demonstrate that the practice is cost efficient. But if it does
save money, who should receive those savings? Obviously, the person
who is paying for the device or service should reap the benefits. The
difficulties surrounding how to return the savings to the patient would
create an accounting maze. The claims of costs savings do not currently
take into account how much money will be needed to bring reprocessors
into compliance with all applicable FDA regulations or how much money
the FDA will need to monitor properly the reprocessors.
Considering all of the problems, risks and unknown solutions to the
issues created by the reuse of single-use only medical devices, much work
must be done before, if ever, the practice is found acceptable. The issues
surrounding reuse remain unresolved.
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